100 Summer Street, 30th Floor, Boston, Massachusetts 02110-2106

Byetta and Januvia

Linked to Pancreatitis, Pancreatic Cancer, and Thyroid Cancer

Our firm is investigating potential lawsuits on behalf of patients who suffered from pancreatitis, pancreatic cancer or thyroid cancer related to the use of glucagon-like peptide-1-based therapies such as Byetta (exenatide) and Januvia (sitagliptin).

These two medications are prescription medicines used to treat Type 2 diabetes, which occurs when there is not enough insulin to break down sugar in the body.

Byetta and Januvia are is a GLP-1 agonist, meaning that it tries to help increase the activity of the hormone. Glucagon-like peptide-1 (GLP-1) is a gut hormone that helps secrete insulin. Research has linked glucagon-like peptide -1-based therapies such as this to an increased risk of pancreatitis, pancreatic cancer and thyroid cancer.

In 2011, Gastroenterology journal published a study definitively linking pancreatitis, pancreatic cancer and thyroid cancer to GLP-1 based therapies. The study, conducted by researchers at the University of California, Los Angeles (UCLA) found a higher incidence of pancreatitis and pancreatic cancer associated with Byetta and Januvia compared with other therapies. Furthermore, researchers also found a significantly higher rate of thyroid cancer linked to the use of Byetta.

For a free evaluation of your case, please contact us by filing our online form, or by calling our toll-free number: 1-888-341-1405.

Byetta, Januvia and Pancreatitis

Pancreatitis is inflammation of the pancreas, the organ responsible for secreting digestive enzymes. It is also involved in regulating blood sugar because it releases the hormones insulin and glucagon. Pancreatitis occurs when the digestive enzymes become active while still inside the pancreas (instead of the small intestine). This condition, which can occur acutely or develop as chronic condition, can cause damage to the pancreas. Signs of acute pancreatitis include:

  • Upper abdominal pain that may radiate to the back
  • Swollen and tender abdomen
  • Nausea
  • Vomiting
  • Fever
  • Increased heart rate

According to the Gastroenterology study, pancreatitis was six times more common among patients who took Byetta compared to those who took an alternative type 2 diabetes therapy.

How we can help

Thornton Law Firm LLP has been a leader in investigating and pursuing compensation for consumers who have been injured by defective drugs and medical devices for more than 30 years. We have a team of attorneys dedicated to this complex area of law. We understand your rights, what is at stake, and how to handle drug claims from beginning to end. For a free evaluation of your case, please contact us by filing our online form, or by calling our toll-free number: 1-888-341-1405.

Links:

Quick Facts

Januvia Reference Guide

Generic Name

  • sitagliptin phosphate

Date Approved

  • 10/17/2006

Manufacturer

  • Merck & Co., Inc.

Status

  • On the market

Approved Uses

  • Treatment of type 2 diabetes

Serious Side Effects

  • Pancreatitis
  • Renal impairment
  • Thyroid cancer
  • Pancreatic cancer

Contact Us


Boston's Top Rated Lawyers Super Lawyers AV Peer Reviewed Rated Preeminent

Thornton Law Firm LLP is located in Boston, Massachusetts and serves clients in and around Boston, Revere, Chelsea, Charlestown, Brighton, Somerville, Allston, Everett, Winthrop, Mattapan, Cambridge, Jamaica Plain, Brookline, Roslindale, Malden, Readville, Newtonville, Newton Center, Arlington, Melrose, West Roxbury, Milton, Newton Highlands, Essex County and Suffolk County.

Attorney Advertising. This website is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship.
[ Site Map ] [Video Center ]